The device acts on the supraorbital nerve and supratrochlear nerve, the nerves that transmit migraine pain. The Food and Drug Administration (FDA) has cleared WAT Medical’s HeadaTerm 2 as an ...

Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine can reduce the risk of complications following ...

Of 500 physicians surveyed, 162 (32%) returned the survey. Characteristics of the respondents are displayed in Table I. The vast majority of physicians were male (87%) specializing in either ...

The Bill & Melinda Gates Foundation has teamed up with Intarcia Therapeutics to invest upwards of $140 million with the intent of developing the first once or twice-yearly anti-HIV prophylactic to ...

"The purpose of this study was to prospectively compare the use of the ActiveCare® [MCS Inc.; West Hills, California] mobile compression device with the use of warfarin therapy in regard to safety and ...

The sponsor submitted a de novo cost analysis using a decision tree model that estimated the cost associated with the geko device compared with no mechanical prophylaxis. The model population was ...

Urokinase administration every 2 weeks significantly affects the rate of occlusive events in ports and tunneled catheters and of infectious events in external catheters compared with heparin ...